MRI medical device firm Bot Image has released artificial intelligence software that improves the accuracy and speed of prostate cancer detection.
QT Prostate MRI has been trained on MRI image sets, radiologist interpretations, and laboratory results. It detects suspicious lesions in the prostate and assigns a cancer probability score. It is available for use for case reviews and training in identifying possible prostate cancer, the company said.
Bot Image is an offshoot of MRI coil developer ScanMed.
